DSG, Inc. Partners with Biotech Company to Battle Progressive and Chronic Kidney Disease
2/1/2010 10:01:13 AM
MALVERN, Pa.--(BUSINESS WIRE)--DSG’s eCaseLink™ Electronic Data Capture (EDC) and data management are currently being used by a biotechnology company for two current phase 2 and phase 2a clinical trials for treatments of progressive and chronic kidney disease. The company uses DSG’s eCaseLink™ to automate and manage the data collection process during the clinical trial lifecycle. In addition, DSG combines data management services with eCaseLink™ to seamlessly optimize data collection and analysis.